Test Code LAB1232526 Enterovirus, Molecular Detection, PCR, Varies
Performing Laboratory
Mayo Clinic Laboratories in Rochester
Reporting Name
Enterovirus PCRSpecimen Type
VariesOrdering Guidance
This test will detect enterovirus but will not differentiate viruses in this family or provide serotyping information.
Necessary Information
1. Specimen source is required.
2. Source information must include main anatomical site of collection.
Specimen Required
Submit a raw clinical sample (not a culture isolate) for enterovirus testing.
Submit only 1 of the following specimens:
Specimen Type: Body fluid
Sources: Pericardial, peritoneal
Container/Tube: Sterile container
Specimen Volume: 0.5 mL
Collection Instructions: Do not centrifuge.
Specimen Type: Spinal fluid
Container/Tube: Sterile vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Submit specimen from collection vial 2.
2. Do not centrifuge.
Specimen Type: Swab
Sources: Dermal, eye, rectal, genital, nasopharyngeal, oropharyngeal, throat, nasal, or urethral
Supplies:
-Culturette (BBL Culture Swab) (T092)
-E-Swab (T853)
-M4-RT (T605)
Container/Tube: Multimicrobe media (M4-RT, M4, M5, Bartels, or Jiangsu) and E-Swab or Culturette
Specimen Volume: Entire specimen
Collection Instructions:
1. Rectal swab must have no visible fecal matter
2. Place swab back into multimicrobe media.
Specimen Type: Respiratory
Sources: Bronchial washing, bronchoalveolar lavage, nasopharyngeal aspirate or washing, pleural fluid, sputum, or tracheal aspirate
Container/Tube: Sterile container
Specimen Volume: 1.5 mL
Collection Instructions: Do not centrifuge.
Reject Due To
| Calcium alginate-tipped swab | Reject |
| Wood swab | Reject |
| Transport swab containing gel | Reject |
| Heat-inactivated specimen | Reject |
| Dry/flocked ESwabs | Reject |
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Varies | Refrigerated (preferred) | 7 days |
| Frozen | 7 days |
Specimen Minimum Volume
Body and respiratory fluids: 0.5 mL; Spinal fluid: 0.3 mL; Swab: See Specimen Required
Special Instructions
Day(s) Performed
Monday through Sunday
Specimen Retention Time
7 daysReport Available
2 to 3 daysReference Values
Negative
Useful For
Aiding in diagnosing enterovirus infections
This test should not be used to screen asymptomatic patients.
Testing Algorithm
For information see Meningitis/Encephalitis Panel Algorithm
CPT Code Information
87498
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| LENT | Enterovirus PCR | 93856-3 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| SRC68 | Specimen Source | 31208-2 |
| 80066 | Enterovirus PCR | 93856-3 |
Method Description
For this real-time reverse-transcription laboratory-developed polymerase chain reaction (PCR) assay, viral nucleic acid is extracted from specimens, followed by amplification and detection on the Roche LightCycler 480 instrument. This PCR assay has been optimized to detect a target sequence in the polyprotein region. Primers amplify a 193 base-pair product.
Enterovirus genomic RNA is first transcribed to complementary DNA (cDNA) by reverse transcriptase, followed by amplification of the cDNA product. The LightCycler instrument can rapidly (30-40 minutes) detect amplicon development through stringent air-controlled temperature cycling in capillary cuvettes. The detection of amplified products is based on the fluorescence resonance energy transfer (FRET) principle. For FRET product detection, a hybridization probe with a donor fluorophore, fluorescein, on the 3'-end is excited by an external light source and emits light that is absorbed by a second hybridization probe with an acceptor fluorophore, LC-Red 640, at the 5'-end. The acceptor fluorophore then emits light of a different wavelength that can be measured with a signal proportional to the amount of specific PCR product. FRET (with subsequent production of a detectable fluorescent signal) only occurs when the probes have specifically annealed to the target sequence of the amplicon.
Melting-curve analysis is performed following PCR amplification and is the detection phase of the assay, since it offers greater sensitivity than the amplification phase and maintains high specificity.
The melting phase of the assay occurs as follows:
Starting at 45° C, which allows the probes to bind to the amplified product, the temperature in the thermal chamber is then slowly raised to 80° C and the fluorescence measured at frequent intervals to determine the point where half of the fluorescence is lost as the probes are denatured (ie, "melt") off of the target. This is called the melting temperature (Tm) of that virus. Analysis of the PCR amplification and probe melting curves is accomplished through the use of LightCycler software. (Kies KD, Thomas AS, Binnicker MJ, Bashynski KL, Patel R. Decrease in Enteroviral Meningitis: An Unexpected Benefit of Coronavirus Disease 2019 [COVID-19] Mitigation. Clin Infect Dis. 2021;73(9):e2807-e2809; Bernard PS, Reiser A, Pritham GH. Mutation detection by fluorescent hybridization probe melting curves. In: Meuer S, Wittwer C, Nakagawara K, eds. Rapid Cycle Real-Time PCR Methods and Applications. Springer; 2012:11-20)
Supportive Data
Accuracy/Diagnostic Sensitivity and Specificity:
Mayo Clinic Laboratories compared the detection of enteroviruses from spinal fluid by conventional tube cell culture (MCR-5) and by LightCycler polymerase chain reaction (PCR). Of 715 specimens tested, enteroviruses were detected in 65 (9%) by conventional cell culture and 82 (11%) by LightCycler PCR. Twenty-two of 82 (27%) were exclusively positive by PCR, whereas only 5 of 65 (8%) were exclusively positive by conventional cell cultures.
Supplemental Data (Spiking Studies):
To supplement the data above, 30 or more negative specimens of each specimen type (spinal fluid/sterile body fluid, dermal/ocular/rectal swabs, plasma, and upper and lower respiratory specimens) were spiked with enterovirus culture control at approximately 10 to 50 targets/mcL (the approximate limit of detection). The spiked specimens were run in a blinded manner along with negative (non-spiked) specimens of each specimen type. Of the spiked specimens, 97% to 100% were positive, and 100% of the non-spiked specimens were negative. A total of 489 spiked and non-spiked specimens were tested.
Assay Inclusivity:
The assay detected all 64 members of an enterovirus panel, consisting of coxsackieviruses, polio viruses, echoviruses, and other enteroviruses. Importantly, the detection of parechovirus serotypes was found to be variable.
Analytical Specificity/Limit of Detection:
The lower limit of detection of this assay is approximately 10 to 50 RNA target copies/mcL. This was confirmed in all specimen types accepted for this assay.
Specificity:
The assay cannot reliably distinguish between enterovirus and rhinovirus. However, no cross-reactivity was observed when a specificity panel was tested, including influenza A/B, respiratory syncytial virus, parainfluenza virus, herpes simplex virus, Epstein-Barr virus, varicella zoster virus, and cytomegalovirus.
Reportable Range:
This is a qualitative assay, and results are reported as either negative or positive for targeted enterovirus RNA.
Forms
If not ordering electronically, complete, print, and send a Microbiology Test Request (T244) with the specimen.